Amedisys (AMED) got here out with quarterly earnings of $1.15 per share, beating the Zacks Consensu
Amedisys (AMED) got here out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $0.90 per share. This compares to earnings of $0.95 per share a 12 months in the past. These figures are adjusted for non-recurring gadgets.
This quarterly report represents an earnings shock of 27.78%. 1 / 4 in the past, it was anticipated that this dwelling well being care and hospice companies supplier would submit earnings of $0.97 per share when it truly produced earnings of $1.21, delivering a shock of 24.74%.
During the last 4 quarters, the corporate has surpassed consensus EPS estimates 4 occasions.
Amedisys, which belongs to the Zacks Medical – Outpatient and Residence Healthcare trade, posted revenues of $494.63 million for the quarter ended September 2019, surpassing the Zacks Consensus Estimate by 0.01%. This compares to year-ago revenues of $417.34 million. The corporate has topped consensus income estimates 4 occasions over the past 4 quarters.
The sustainability of the inventory’s…